Title: Conservative management of tubercular intestinal obstruction with antitubercular drugs and steroid
Authors: Dr Jayesh Kalbhande, Dr Mayank Chaudhary
DOI: https://dx.doi.org/10.18535/jmscr/v12i02.05
Abstract
Objective: Tubercular intestinal obstruction is a challenging condition often necessitating surgical intervention. This case study aims to evaluate the effectiveness of conservative management, including antitubercular therapy, short-course steroids, and dietary modifications, in resolving acute and complete intestinal obstruction caused by tuberculosis.
Case Description: A 17-year-old malnourished male presented with acute abdominal pain, vomiting, and constipation. Imaging revealed mid-ileal intestinal obstruction due to tuberculosis. Conservative management, involving intravenous antibiotics, nasogastric decompression, steroids, and antitubercular treatment, led to gradual resolution. The patient experienced recurrent partial obstruction episodes, each managed conservatively with antibiotics, steroids, and dietary adjustments. A slow transition from liquid to solid diet accompanied recovery. After a year of treatment, the patient achieved recovery with weight gain.
Conclusion: Tubercular intestinal obstruction, challenging to treat medically, often requires surgery. However, this case demonstrates the successful outcome through a comprehensive conservative approach. The inclusion of steroids alongside antitubercular treatment played a crucial role. Additionally, a cautious transition from liquid to solid diet post-resolution proved effective in preventing recurrence. Conservative management, when tailored to the patient's nutritional needs and disease course, can lead to favorable outcomes in tubercular intestinal obstruction.
References
- World Health Organization. (2023, April 21)
- Keena M, Chawla G, Sonika U, Abrol N, Hiremath S, Meena VK. Indian tubercular belly: A prospective study of 140 patients of abdominal tuberculosis and their outcomes. J Family Med Prim Care. 2022 Jun;11(6):2423-2430. doi: 10.4103/jfmpc.jfmpc_1198_21. Epub 2022 Jun 30. PMID: 36119178; PMCID: PMC9480814
- Rosado E, Penha D, Paixao P, Costa AMD, Amadora PT. Abdominal tuberculosis - Imaging findings. Educational exhibit; ECR. 2013:C–0549.
- World Health Organisation, Global tuberculosis report 2019, Geneva:
- Aggarwal P, Kedia S, Sharma R, et al. Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy. Dig Dis Sci. 2017;62(10):2847‐2856. doi:10.1007/s10620-017-4727-3
- Soni H, Bellam BL, Rao RK, et al. Use of steroids for abdominal tuberculosis: a systematic review and meta-analysis. Infection. 2019;47(3):387‐394. doi:10.1007/s15010-018-1235-0
- Kadhiravan, S. Deepanjali, Role of Corticosteroids in the Treatment of Tuberculosis: An Evidence-based Update, The Indian Journal of Chest Diseases & Allied Sciences, 2010;Vol.52, 153-158
- Abdulrahman A. Alrajhi, Magid A et. al. Corticosteroid Treatment of Peritoneal Tuberculosis, Clinical Infectious Diseases 1998; 27:52 – 6
- Gräb, J., Suárez, I., van Gumpel, E. et al. Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition. Nat Commun 10, 688 (2019). https://doi.org/10.1038/s41467-019-08405-9
- Debi U, Ravisankar V, Prasad KK, Sinha SK, Sharma AK. Abdominal tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol. 2014;20(40):14831‐14840. doi:10.3748/wjg.v20.i40.14831